Prizor Excavator
1 / 5
Indocyanine green (ICG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm, emitting near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, then enters the intestine through the biliary tract, and finally is excreted with feces.
This product represents the first indocyanine green injection in China that has passed the double consistency evaluation by international standards in the United States and Japan. With high purity, low impurity content, and optimized storage conditions, it provides stable and reliable diagnosis and treatment options to the medical community.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, fluorescent staining helps identify target membranes accurately and reduces intraoperative complications.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, complicated biliary tract development, and bile leakage observation.
Advantages: High rapidity, accuracy, and safety make it the optimal method for liver reserve function evaluation. Fluorescence characteristics help physicians identify liver structure clearly, improving surgical safety.
Indications: Accurate localization of tumors, image development of the lymphatic system, and assessment of blood supply.
Advantages: The fluorescence signal makes it intuitive to judge targets, enhancing visibility during operations.
Products include research, development, production, and sales of high-end medical devices (fluorescence imaging series), fluorescence contrast agent drugs (ICG, targeted series), and core components (CMOS camera modules, endoscopes), providing a full-chain solution used in more than 500 large hospitals.
Holding 131 core invention patents and 7 US invention patents, the enterprise has undertaken numerous national and provincial key research projects. As a strategic partner of leading international companies in Germany and Japan, cooperative businesses have been established in over 10 overseas countries.
